A. Belonogov

RESOLUTION ON THE RESULTS OF SCIENTIFIC-PRACTICAL CONFERENCE "CLINICAL EVIDENCE OF INCREASING OVERALL SURVIVAL IN THE TREATMENT OF METASTATIC BREAST CANCER", HELD ON

N. Zhukov, I. Shumskaya, E. Bairamov, 2015 .

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer

V. Moiseenko, F. Moiseenko, L. Bolotina, 2019, Colorectal Oncology.

Efficacy and toxicity of aflibercept and bevacizumab in combination with FOLFIRI in second‑line therapy for metastatic colon cancer: a retrospective multicenter study

L. Bolotina, A. Zhabina, S. Belukhin, 2022, Pelvic Surgery and Oncology.

ALGORITHM OF THE TREATMENT OF THE COMPLICATED COLORECTAL CANCER

V. Dvornichenko, R. Rasulov, A. Shelekhov, 2005 .

Overall Survival of Patients With ALK-Positive Metastatic Non–Small-Cell Lung Cancer in the Russian Federation: Nationwide Cohort Study

E. Imyanitov, S. Tjulandin, F. Moiseenko, 2019, Journal of global oncology.

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

F. Moiseenko, O. Kit, D. Nosov, 2019, Medical Council.